Abraham Jewett , Jon Styf  |  October 31, 2023

Category: Legal News

Top Class Actions’s website and social media posts use affiliate links. If you make a purchase using such links, we may receive a commission, but it will not result in any additional charges to you. Please review our Affiliate Link Disclosure for more information.

Close up of a box of Suboxone films, representing the Suboxone antitrust settlement.
(Photo Credit: a katz/Shutterstock)

Update:

  • Indivior agreed to a $385 million settlement to end claims in a multidistrict litigation regarding Suboxone.
  • A federal judge in Pennsylvania must agree to the settlement. A trial was set to begin Oct. 30.
  • The pharmaceutical company, which develops drugs to treat addiction, says it expects to pay the settlement in November and charge $228 million of it against the company’s Q3 profits.
  • “The resolution of this litigation, which was filed over a decade ago, provides greater certainty for all Indivior stakeholders and allows us to continue focusing on our important work for patients suffering from opioid use disorder and mental health illnesses around the world,” Mark Crossley, Indivior CEO, says in a statement.

Suboxone settlement overview: 

  • Who: Indivior Inc. has agreed to pay $30 million to end claims brought by a class of end payors of Suboxone, an opioid addiction treatment. 
  • Why: The end payors claimed Indivior monopolized the market for Suboxone by allegedly delaying the introduction of cheaper alternatives to the pharmaceutical market. 
  • Where: Nationwide. 

(08/28/2023)

Pharmaceutical company Indivior has agreed to a $30 million settlement to resolve claims it monopolized the market for Suboxone, an opioid addiction treatment. 

The settlement ends more than 10 years of “hard-fought” litigation over claims Indivior “engaged in a fraudulent scheme with respect to Suboxone in violation of state antitrust and consumer protection statutes,” according to a memorandum for settlement approval. 

The end payors argued Indivior’s alleged monopolization of Suboxone caused them to have to pay higher prices for the drug — as well as its generic equivalent — than they would have paid in a competitive market. 

“The proposed Settlement will conclude all claims of End Payors in this litigation against Defendant concerning the alleged suppression of generic competition for Suboxone during the period December 22, 2011 to the date of preliminary approval ,” the memorandum states. 

The settlement requires Indivior to put $30 million into an escrow fund that will be proportioned to the end payors. 

Indivior accused of delaying introduction of cheaper alternatives to Suboxone

Indivior was accused of unlawfully delaying the introduction of cheaper alternatives to Suboxone to the pharmaceutical market, according to the memorandum.

“Indivior is alleged to have implemented a plan to inflate brand Suboxone tablet prices and switch consumers to film, delaying generic Suboxone tablets from entering the market,” the end payors said. 

Indivior has denied the allegations, while the company’s CEO Mark Crossley said in an Aug. 21 statement that the agreement was reached with those who need a drug like Suboxone to help with substance abuse issues in mind, according to Law360.

“We remain focused on helping those suffering from substance use disorders and mental illness,” Crossley said. “Resolving these legacy legal matters at the right value helps us further our mission for patients and creates greater certainty for our stakeholders.”

Indivior previously agreed to pay $102.5 million in June to resolve claims it monopolized the market for Suboxone that was brought against it by state attorneys general from a total of 42 states. 

Have you paid what you believed to be an inflated price for Suboxone? Let us know in the comments! 

The Suboxone case is In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation, Case No. 2:13-md-02445, in the U.S. District Court for the Eastern District of Pennsylvania. 


Don’t Miss Out!

Check out our list of Class Action Lawsuits and Class Action Settlements you may qualify to join!


Read About More Class Action Lawsuits & Class Action Settlements:

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.

108 thoughts onIndivior reaches $385M settlement with direct purchasers over Suboxone

  1. Terri L Crutchfield says:

    I have been on Suboxone on and off since 2004 it was literally torture not being able to afford my Suboxone that times, I swear you can’t trust the doctors these billion dollar companies!! not only have a loss of money. I also lost my teeth due to Suboxone‘s please sign me up for this class actions lawsuit!!!

  2. Amy Latimer says:

    How do I apply for this class action lawsuit?

  3. sonya Strait says:

    Yes on pain pills and could not afford Suboxone at the time nor could my husband that is dead now along with many other people because Suboxone was to high

  4. Carla Sadler says:

    I have been on Brand Name Suboxone since 2006 – almost everything about this drug is deceptive and the extremely expensive – time consuming – degrading anxiety producing criteria to be on this drug is outrageous – up until approximately two to three years ago ( prior to being able to see a pcp) a person was Forced to participate in Prison boot camp Cash Cow type special clinic programs to be able to take Suboxone – deceived about the effects, benefits and how hard it is to taper off the drug – not to mention the dental risks – I have lost six bottom teeth from taking Suboxone. My husband also took Suboxone for about two years and spent more time tapering than he did at the therapeutic dose.

  5. Karen says:

    I have been on suboxone since 2004. I have bean clean since then. I had to choose that over methadone do to unable to get to clinic and at that time more private in a pcp clinic atmosphere. Then lining up to take a dose of methadone and it was suppose to be easier to taper off and safer than the methadone

  6. Amanda Tomany says:

    Contact me yes overpaid

  7. joshua brown says:

    how do i submit a claim

  8. Ann says:

    Well well well….i stayed on opiates for a year longer than I wanted to because I could not afford to get help and I couldn’t handle cold turkey because I was working 2 full time jobs. It wasn’t until my brother finally stepped in and paid for it that i was able to get clean…..ive been clean for 4 years now. We had to pay the doctor 300 in CASH and a little over 300 for the 30 day prescription, monthly!!! I was already devalued and robbed enough only for the medical and pharm community to make it worse. I knew then it was a lie that they really wanted to help us. Thank God, though, it was just as Fentanyl was making the scene. 2 people i knew that wanted help but couldnt afford it are dead now from the fentayl that was being faked as Roxy 30s. My blood is boiling right now and I can’t see straight.

  9. JENNIFER BLACK says:

    How do I apply for this Suboxone refund lawsuit?

  10. JENNIFER BLACK says:

    How do I apply for this???

    1. John says:

      Please put my name in this Suboxone class action

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.